Abstract
Neuroendocrine tumours (NET) comprise a large variety of rare and heterogeneous tumours with an estimated incidence of 3–5/100,000/year. They can arise in virtually every internal organ, but mainly occur in the gastroenteropancreatic and bronchopulmonary systems. Gastrointestinal and pancreatic neuroendocrine tumours (GEP-NET) include various types of solid tumours arising from the secretory cells of the neuroendocrine cell system; they can occur anywhere along the gastrointestinal tract.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.
Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system, vol. 3. 4th ed. Lyon: IARC Press; 2010.
Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell; 2009.
Edge SB, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Hörsch D, Schmid KW, Anlauf M, Darwiche K, Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, Heigener DF, Serke M, Kegel T, Pavel M, Waller CF, Deppermann KM, Arnold R, Huber RM, Weber MM, Hoffmann H. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Oncol Res Treat. 2014;37(5):266–76.
Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717–51.
Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25:458–511.
Modlin IM, et al. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Aust. 2010;193:46–52.
Ambrosini V, Tomassetti P, Franchi R, Fanti S. Imaging of NET with PET radiopharmaceuticals. Q J Nucl Med Mol Imaging. 2010;54:16–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Campana, D., Tomassetti, P. (2016). Incidence, Epidemiology, Aetiology and Staging, Classification, Clinical Presentation/Signs and Symptoms, Diagnosis, Staging Procedures/Investigation. In: Ambrosini, V., Fanti, S. (eds) PET/CT in Neuroendocrine Tumors. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-29203-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-29203-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29202-1
Online ISBN: 978-3-319-29203-8
eBook Packages: MedicineMedicine (R0)